RAF inhibitors unexpectedly induce ERK signaling in normal and tumor cells with elevated RAS activity. Paradoxical activation is believed to be RAS dependent. In this study, we showed that LY3009120, a pan-RAF inhibitor, can unexpectedly cause paradoxical ERK activation in KRAS(G12C)-dependent lung cancer cell lines, when KRAS is inhibited by ARS1620, a KRAS(G12C) inhibitor. Using H/N/KRAS-less mouse embryonic fibroblasts, we discovered that classical RAS proteins are not essential for RAF inhibitor-induced paradoxical ERK signaling. In their absence, RAF inhibitors can induce ERK phosphorylation, ERK target gene transcription, and cell proliferation. We further showed that the MRAS/SHOC2 complex is required for this process. This study hig...
BackgroundRaf is a proto-oncogene that is activated in response to growth factors or phorbol esters,...
SummaryRas activation is common to many human cancers and promotes cell proliferation and survival b...
We discuss the biology of Ras signal transduction and the epidemiology of ras mutations in associati...
RAF inhibitors unexpectedly induce ERK signaling in normal and tumor cells with elevated RAS activit...
Oncogenic RAS (Rat sarcoma) mutations drive more than half of human cancers, and RAS inhibition is t...
SummaryKRAS is the most frequently mutated oncogene in human cancer, yet no therapies are available ...
Clinically used RAF inhibitors are ineffective in RAS-mutant tumors because they enhance homo- and h...
SummaryRAF kinase inhibitors can induce ERK cascade signaling by promoting dimerization of RAF famil...
SummaryBRAFV600E drives tumors by dysregulating ERK signaling. In these tumors, we show that high le...
Tumours with mutant BRAF are dependent on the RAF-MEK-ERK signalling pathway for their growth. We fo...
BRAFV600E drives tumors by dysregulating ERK signaling. Here we show that, in these tumors, high le...
Tumors with mutant BRAF are dependent on the RAF/MEK/ERK signaling pathway for their growth1-3. We f...
Background: Raf is a proto-oncogene that is activated in response to growth factors or phorbol ester...
The Ras-Raf-MEK-ERK signaling pathway, the first well-established MAPK pathway, plays essential role...
The intricate dynamic control and plasticity of RAS to ERK mitogenic, survival and apoptotic signall...
BackgroundRaf is a proto-oncogene that is activated in response to growth factors or phorbol esters,...
SummaryRas activation is common to many human cancers and promotes cell proliferation and survival b...
We discuss the biology of Ras signal transduction and the epidemiology of ras mutations in associati...
RAF inhibitors unexpectedly induce ERK signaling in normal and tumor cells with elevated RAS activit...
Oncogenic RAS (Rat sarcoma) mutations drive more than half of human cancers, and RAS inhibition is t...
SummaryKRAS is the most frequently mutated oncogene in human cancer, yet no therapies are available ...
Clinically used RAF inhibitors are ineffective in RAS-mutant tumors because they enhance homo- and h...
SummaryRAF kinase inhibitors can induce ERK cascade signaling by promoting dimerization of RAF famil...
SummaryBRAFV600E drives tumors by dysregulating ERK signaling. In these tumors, we show that high le...
Tumours with mutant BRAF are dependent on the RAF-MEK-ERK signalling pathway for their growth. We fo...
BRAFV600E drives tumors by dysregulating ERK signaling. Here we show that, in these tumors, high le...
Tumors with mutant BRAF are dependent on the RAF/MEK/ERK signaling pathway for their growth1-3. We f...
Background: Raf is a proto-oncogene that is activated in response to growth factors or phorbol ester...
The Ras-Raf-MEK-ERK signaling pathway, the first well-established MAPK pathway, plays essential role...
The intricate dynamic control and plasticity of RAS to ERK mitogenic, survival and apoptotic signall...
BackgroundRaf is a proto-oncogene that is activated in response to growth factors or phorbol esters,...
SummaryRas activation is common to many human cancers and promotes cell proliferation and survival b...
We discuss the biology of Ras signal transduction and the epidemiology of ras mutations in associati...